NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the 26th Annual JPMorgan Healthcare Conference in San Francisco on Tuesday, January 8, 2008 at 4:30 p.m. PST. A corporate overview will be provided, including additional information on the Company’s product portfolio.
